Tsuyoshi Iwata
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
MR Imaging/Ultrasound Fusion-Guided Biopsy and Primary Focal Therapy for Localized Prostate Cancer.
Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
Published: June 03, 2026
A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI
Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published: July 14, 2023
Intraoperative ultrasonography in laparoscopic off-clamp partial nephrectomy for renal cell carcinoma adjacent to multiple renal cysts: a case report.
Journal: Journal of medical ultrasonics (2001)
Published: February 24, 2023
Time-course changes in multiparametric magnetic resonance imaging following focal cryotherapy for localized prostate cancer: Initial experience.
Journal: European journal of radiology
Published: November 17, 2022
Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan.
Journal: Molecular and clinical oncology
Published: July 22, 2022
Intraoperative ultrasound monitoring with superb microvascular imaging in focal cryotherapy for prostate cancer.
Journal: Journal of medical ultrasonics (2001)
Published: January 14, 2022
Can We Avoid a Systematic Biopsy in Men with PI-RADS® 5? Reply.
Journal: The Journal of urology
Published: October 19, 2021
Clinical, pathological, and therapeutic features of newly diagnosed prostate cancer predominantly detected by opportunistic PSA screening: A survey of Shiga Prefecture, Japan.
Journal: The Prostate
Published: April 08, 2021
Systematic Biopsy of the Prostate can Be Omitted in Men with PI-RADS™ 5 and Prostate Specific Antigen Density Greater than 15.
Journal: The Journal of urology
Published: April 05, 2021
Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up.
Journal: World journal of urology
Published: October 19, 2020
Last Updated: 09/26/2026